Archit Organosys Valuation Multiples
Archit Organosys is valued at $15M as of November 2026, a 1.3x revenue multiple. In the last fiscal year, Archit Organosys revenue was $14M and Archit Organosys EBITDA was $2M.
Archit Organosys Overview
About Archit Organosys
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
Founded
1993
HQ
Employees
51
Website
Financials (Last FY)
EV
$18M
Valuation Multiples
Start free trial
Archit Organosys Financials
Archit Organosys reported last fiscal year revenue of $14M and EBITDA of $2M.
In the same fiscal year, Archit Organosys generated $3M in gross profit, $2M in EBITDA, and $854K in net income.
Archit Organosys P&L
In the most recent fiscal year, Archit Organosys reported revenue of $14M and EBITDA of $2M.
Archit Organosys is profitable as of last fiscal year, with gross margin of 18%, EBITDA margin of 12%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Archit Organosys Stock Performance
Archit Organosys has current market cap of $15M, and enterprise value of $18M.
Market Cap Evolution
Archit Organosys' stock price is $0.74.
Archit Organosys share price increased by 7.0% in the last 30 days.
Archit Organosys has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18M | $15M | 0.0% | 7.0% | - | - | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialArchit Organosys Valuation Multiples
Archit Organosys trades at 1.3x EV/Revenue multiple, and 10.1x EV/EBITDA.
Archit Organosys Financial Valuation Multiples
As of November 9, 2026, Archit Organosys has market cap of $15M and EV of $18M.
Archit Organosys has a P/E ratio of 17.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Archit Organosys Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Archit Organosys Margins & Growth Rates
In the most recent fiscal year, Archit Organosys reported gross margin of 18%, EBITDA margin of 12%, and net margin of 6%.
Archit Organosys Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Archit Organosys Operational KPIs
Archit Organosys' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Archit Organosys Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Archit Organosys competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Archit Organosys
Archit Organosys has acquired 1 company to date.
Last acquisition by Archit Organosys was on September 3rd 2026. Archit Organosys acquired Archit Life Science for undisclosed valuation.
Latest Acquisitions by Archit Organosys
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Archit Life Science | |
| Description | Archit Life Science is an Indian chemical manufacturer based in Ahmedabad, Gujarat, incorporated in 2022 as a public unlisted company. It was set up by Archit Organosys, a listed Indian chemicals producer, as a subsidiary to build a new manufacturing project. The planned product range covers acetate solvents, namely ethyl acetate, butyl acetate and propyl acetate, together with acetaldehyde, which are used as intermediates and solvents in coatings, inks, adhesives, pharmaceuticals and agrochemicals. Its customers are industrial manufacturers and chemical formulators, and it earns revenue from the sale of these products. Its plant location is in the Naroda industrial estate of Ahmedabad and its registered office is in the same city. In 2026 the parent agreed to take a controlling stake in the company through a share swap, bringing the business more closely under the parent's chemicals operations. |
| HQ Country | |
| HQ City | Ahmedabad |
| Deal Date | 3 Sep 2026 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Archit Organosys acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Archit Organosys
| When was Archit Organosys founded? | Archit Organosys was founded in 1993. |
| Where is Archit Organosys headquartered? | Archit Organosys is headquartered in India. |
| How many employees does Archit Organosys have? | As of today, Archit Organosys has over 51 employees. |
| Is Archit Organosys publicly listed? | Yes, Archit Organosys is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Archit Organosys? | Archit Organosys trades under 524640 ticker. |
| When did Archit Organosys go public? | Archit Organosys went public in 1995. |
| Who are competitors of Archit Organosys? | Archit Organosys main competitors include |
| What is the current market cap of Archit Organosys? | Archit Organosys' current market cap is $15M. |
| What is the current revenue of Archit Organosys? | Archit Organosys' last fiscal year revenue is $14M. |
| What is the current EV/Revenue multiple of Archit Organosys? | Current revenue multiple of Archit Organosys is 1.3x. |
| Is Archit Organosys profitable? | No, Archit Organosys is not profitable. |
| How many companies Archit Organosys has acquired to date? | As of November 2026, Archit Organosys has acquired 1 company. |
| What was the largest acquisition by Archit Organosys? | None of the M&A deals Archit Organosys has completed have disclosed valuations. |
| What companies Archit Organosys acquired? | Archit Organosys acquired Archit Life Science. |
| In how many companies Archit Organosys has invested to date? | Archit Organosys hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Archit Organosys
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.